Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Published in Respiratory Medicine

Journal Scan / Research · December 07, 2021

Outcomes of Durvalumab With Platinum–Pemetrexed in the Management of Unresectable Pleural Mesothelioma

Nature Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Emmett Kistler MD

Nature Medicine

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nat. Med. 2021 Nov 01;27(11)1910-1920, PM Forde, V Anagnostou, Z Sun, SE Dahlberg, HL Kindler, N Niknafs, T Purcell, R Santana-Davila, AZ Dudek, H Borghaei, M Lanis, Z Belcaid, KN Smith, A Balan, JR White, C Cherry, IK Ashok Sivakumar, XM Shao, HY Chan, D Singh, S Thapa, PB Illei, DM Pardoll, R Karchin, VE Velculescu, JR Brahmer, SS Ramalingam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Outcomes of Durvalumab With Platinum–Pemetrexed in the Management of Unresectable Pleural Mesothelioma

Additional Info

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Further Reading

Efficacy of Nirmatrelvir in the Treatment of Vaccinated or Unvaccinated Adult Outpatients With COVID-19

Pathophysiology, Clinical Impact, and Management of Atrial Arrhythmias Among Patients With Pulmonary Hypertension

Challenges Associated With the Initiation and Management of ECMO Support

Association Between Emergency-Authorized Nonconventional Ventilator Use and Mortality Among Patients With COVID-19–Associated ARDS

Comparison Between Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting TB

Effect of Enteral vs Parenteral Phosphate Replacement on Biochemistry, Waste, and Environmental Impact and Healthcare Cost Among Patients With Critical Illness With Mild to Moderate Hypophosphatemia

Flow Cytometry as an Alternative to Microscopy for the Differentiation of Bronchoalveolar Lavage Fluid Leukocytes

Racial Differences in Respiratory Impairment, Pneumoconiosis, and Federal Compensation Among Indigenous Coal Miners in Western US

Delirium and Incident Dementia Among Patients Admitted to Hospitals in New South Wales, Australia

Effectiveness of an Artificial Intelligence–Enabled Intervention for Detecting Clinical Deterioration

Inappropriate Diagnosis of Pneumonia Among Hospitalized Adults

Recently Updated